In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents

被引：194
|
作者：
Almyroudis, Nikolaos G.
Sutton, Deanna A.
Fothergill, Annette W.
Rinaldi, Michael G.
Kusne, Shimon
机构：
[1] Roswell Pk Canc Inst, Dept Med, Buffalo, NY USA
[2] Dept Pathol, Fungus Testing Lab, San Antonio, TX USA
[3] Audie L Murphy Mem Vet Adm Med Ctr, S Texas Vet Hlth Care Syst, San Antonio, TX USA
[4] Mayo Clin, Phoenix, AZ USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 07期
关键词：
D O I：
10.1128/AAC.00452-07
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro susceptibilities of 217 zygomycetes to amphotericin B, ketoconazole, fluconazole, itraconazole, voriconazole, posaconazole, caspofungin, and flucytosine. The significant in vitro activity of posaconazole against several species appears to support its reported clinical efficacy. Decreased susceptibility to amphotericin B was noted with Cunninghamella bertholletiae.
引用
收藏
页码：2587 / 2590
页数：4
相关论文
共 50 条
  • [41] In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents
    Homa, Monika
    Galgoczy, Laszlo
    Toth, Eszter
    Viragh, Mate
    Chandrasekaran, Muthusamy
    Vagvolgyi, Csaba
    Papp, Tamas
    MEDICAL MYCOLOGY, 2016, 54 (07) : 776 - 779
  • [42] In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi
    González, GM
    Sutton, DA
    Thompson, E
    Tijerina, R
    Rinaldi, MG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) : 633 - 635
  • [43] In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
    Tay, S. T.
    Haryanty, T. Tanty
    Ng, K. P.
    Rohani, M. Y.
    Hamimah, H.
    MYCOSES, 2006, 49 (04) : 324 - 330
  • [44] In vitro, Susceptibilities of Clinical Yeast Isolates to Antifungal Drugs of Polyene, Pyrimidine, and Azoles, and their Effect in Yeast Adhesion and Mycelial Formation
    Kabli, Saleh A.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2008, 15 (02) : 189 - 198
  • [45] In vitro activity of current and new antifungal agents against Spanish clinical isolates of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis
    Miranda Zapico, I.
    Eraso, E.
    Hernandez Almaraz, J. L.
    Carrillo Munoz, A. J.
    Hernandez Molina, J. M.
    Guillermo Quindos, G.
    MYCOSES, 2009, 52 : 34 - 34
  • [46] Antifungal susceptibilities of 113 clinical isolates of Cryptococcus neoformans and candida SP to the new antifungal albaconazole (UR9825) respect to voriconazole and fluconazole
    Morera, Y
    Torres-Rodríguez, J
    Jiménez, T
    TRENDS IN MEDICAL MYCOLOGY, 2003, : 143 - 147
  • [47] In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    Barchiesi, F
    Tortorano, AM
    Di Francesco, LF
    Cogliati, M
    Scalise, G
    Viviani, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 295 - 299
  • [48] In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei
    Drago, M
    Scaltrito, MM
    Morace, G
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (08) : 619 - 624
  • [49] In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei
    M. Drago
    M. M. Scaltrito
    G. Morace
    European Journal of Clinical Microbiology and Infectious Diseases , 2004, 23 : 619 - 624
  • [50] In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp.
    Gomez-Lopez, A
    Garcia-Effron, G
    Mellado, E
    Monzon, A
    Rodriguez-Tudela, JL
    Cuenca-Estrella, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) : 3085 - 3088
12345